Cover image for Vol. 21 Issue 5

Edited By: Peter G. Kerr

Impact Factor: 2.083

ISI Journal Citation Reports © Ranking: 2014: 31/78 (Urology & Nephrology)

Online ISSN: 1440-1797

Recently Published Issues

See all


Read Free issues
Special Issue: Updates on the erythropoiesis stimulating agents: predialysis anemia management
Virtual Issue: Methods in Renal Research

Increased Impact Factor 2.083!
Read, cite the journal, or submit your paper to keep contributing to the success of Nephrology.
Click here to access the TOP cited articles published in 2014-2015.

Recently Published Articles

  1. Risk factors associated with a decreased estimated glomerular filtration rate based on cystatin C levels in school-age children with extremely low birth weight

    Natsumi Yamamura-Miyazaki, Katsusuke Yamamoto, Kaori Fujiwara, Yoko Santo, Toshimi Michigami, Hiroyuki Kitajima and Kenichi Satomura

    Accepted manuscript online: 28 APR 2016 09:41PM EST | DOI: 10.1111/nep.12807

  2. Impact of Dialysis Requirement on Outcomes in Tumor Lysis Syndrome

    Pranav S.Garimella, Poojitha Balakrishnan, Natraj R.Ammakkanavar, Shanti Patel, Achint Patel, Ioannis Konstantinidis, Narender Annapureddy and Girish N.Nadkarni

    Accepted manuscript online: 27 APR 2016 04:30AM EST | DOI: 10.1111/nep.12806

  3. PLA2R and membranous nephropathy: A 3 year prospective Australian study (pages 397–403)

    Prue A Hill, Jennifer L McRae and Karen M Dwyer

    Article first published online: 22 APR 2016 | DOI: 10.1111/nep.12624

    Summary at a Glance

    This study shows 100% specificity of both serum anti-PLA2R and glomerular PLA2R with a sensitivity of 81% in Australian patients with idiopathic membranous nephropathy.

  4. You have free access to this content
    Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease (pages 363–371)

    Kevin Yao and Sharon D Ricardo

    Article first published online: 22 APR 2016 | DOI: 10.1111/nep.12643

    Summary at a Glance

    Emerging evidence reports that microRNAs (miRNAs) can reduce kidney fibrosis through regulation of targets associated with collagen and extracellular matrix accumulation. Delivery of miRNAs to their cellular targets poses numerous problems. This review discusses the prospect of using combination of miRNAs and mesenchymal stem cells to provide novel cell-based therapy for treating chronic kidney disease.

  5. Interankle systolic blood pressure difference and renal outcomes in patients with chronic kidney disease (pages 379–386)

    Szu-Chia Chen, Yi-Chun Tsai, Jiun-Chi Huang, Su-Chu Lee, Jer-Ming Chang, Shang-Jyh Hwang and Hung-Chun Chen

    Article first published online: 22 APR 2016 | DOI: 10.1111/nep.12619

    Summary at a Glance

    The authors made the novel observation that increased interankle systolic BP difference as a manifestation of peripheral vascular disease was associated with rapid renal progression and progression to renal end points in patients with stage 3–5 CKD. The methodologic ambiguities have been clarified.